Jaguar Health Inc. surged as investors cheered positive clinical trial progress, and its stocks have been trading up by 34.25 ...

At the industry's top events, pharma professionals can dive into these issues and more through educational sessions, networking events and keynote presentations from industry leaders. Here's a look at ...

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find ...

CSL Ltd (ASX: CSL) shares are climbing higher again today. Find out what they could be worth by this time next year.

Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.

Naarden-based venture capital firm Forbion, which specialises in life sciences companies, has raised €2.3 billion for 2 new ...

Virtual Event Featuring Jonathan M. Hernandez, M.D, Investigator, Surgical Oncology Program, NCI/CCR, to Be Held October 15, 2026, at 8am ETPRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- PDS ...

Dutch haul comes despite European drugmakers and investors warning the region is losing ground.

A three-day special programme on agricultural production and development began at the Guwahati Biotech Park in Amingaon on ...

A Scottish biotech firm has secured a £2.5m investment to support a new commercial-scale production facility in Grangemouth.

Forbion has touted its “landmark” 2.3 billion euro ($2.6 billion) fundraise across two funds as a new record for the European ...